Emrusolmin
N/A
Report date: 2026/04/10 20:01:49
NME
Base Information
Drug NameEmrusolmin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLudwig-Maximilians-UniversityMax Planck Institute for Biophysical Chemistry
China Registration ClassN/A
Develop Information
Active CompaniesModag GmbhTeva Branded Pharmaceutical Products R&D LLCTeva Branded Pharmaceutical Products R&D Inc +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A